Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
Venues & MTFs

Lilly's Foundayo Demonstrates Cardiovascular Safety In Landmark Diabetes Study

By Nasdaq Market Structure

Lilly's Foundayo Demonstrates Cardiovascular Safety In Landmark Diabetes Study

(RTTNews) - Wednesday. Eli Lilly and Company (LLY) reported detailed results from the Phase 3 ACHIEVE-4 trial showing that Foundayo (orforglipron) demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in adults with type 2 diabetes and obesity or ov

Read at source

Read also
  1. Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial
  2. Dollar Slips on Reduced Fed Rate Hike Chances
  3. Target's Dividend Has Survived 8 Recessions. Here's What $10,000 Earns in Dividend Income Yearly.
  4. Sugar Prices Fall on Signs of Weak Physical Sugar Demand
  5. Soybeans Fading Post-USDA Report Gains on Spillover Pressure

Source: Nasdaq Market Structure